NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis

Eitemau Tebyg

• Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren’s Syndrome
  gan: Meng, Zhen, et al.
  Cyhoeddwyd: (2017)
• Intra-lacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects Without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren’s Syndrome
  gan: Ju, Yaping, et al.
  Cyhoeddwyd: (2020)
• Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome
  gan: Klinngam, Wannita, et al.
  Cyhoeddwyd: (2019)
• Increased Expression of Cathepsins and Obesity-Induced Proinflammatory Cytokines in Lacrimal Glands of Male NOD Mouse
  gan: Li, Xiaodong, et al.
  Cyhoeddwyd: (2010)
• Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren’s syndrome animal models
  gan: Hawley, Dillon, et al.
  Cyhoeddwyd: (2018)